Multidrug resistant tuberculosis in previously treated and new cases registered between 2004-2008 in Romania Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Our experience and treatment results of multidrug-resistant tuberculosis (MDR-TB) patients between 1996-2002 Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003
Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 Source: Eur Respir J 2010; 36: 584-593 Year: 2010
Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013 Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Treatment outcome of XDR-TB patients in Iran during 2003-2006 Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Mycobacterium tuberculosis drug resistance in child patients, 1989-2000Source: Eur Respir J 2001; 18: Suppl. 33, 472s Year: 2001
Treatment outcome and factors associated with unfavourable treatment results in cases with multidrug-resistant tuberculosis in Bulgaria for the period 2009-2010 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Resistance pattern of tuberculosis patients enrolled to Izmir esrefpasa tuberculosis dispensary between 1996-2001 Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002
Drug resistance of mycobacterium tuberculosis isolates in Serbia over five-year period (2001-2005) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
TB epidemiology and drug resistance in Bulgaria (1990-2003) Source: Eur Respir J 2004; 24: Suppl. 48, 199s Year: 2004
Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010 Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Characteristics of XDR-TB patients in Israel: 2000-2010 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Resistance of Mycobacterium tuberculosis strains to antituberculotic drugs over the period 1999-2000 Source: Eur Respir J 2002; 20: Suppl. 38, 614s Year: 2002
Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012) Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Treatment outcomes of smear-positive pulmonary TB cases in Romania in 2006-2008 Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
The outcome of retreated tuberculosis patients in 2000 and 2001 Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
First national survey results of mycobacterium tuberculosis drug resistance in Kosovo, 2007-2008 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004